220 related articles for article (PubMed ID: 21703834)
1. Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography.
Silbernagel G; Hoffmann MM; Grammer TB; Boehm BO; März W
Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):46-52. PubMed ID: 21703834
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997-2003.
Lin GM; Li YH; Zheng NC; Lai CP; Lin CL; Wang JH; Jaiteh LE; Han CL
J Cardiol; 2013 Feb; 61(2):122-7. PubMed ID: 23088935
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysis.
Wang R; Song Y; Yan Y; Ding Z
Atherosclerosis; 2016 Nov; 254():193-199. PubMed ID: 27755985
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.
Strasak AM; Kelleher CC; Brant LJ; Rapp K; Ruttmann E; Concin H; Diem G; Pfeiffer KP; Ulmer H;
Int J Cardiol; 2008 Apr; 125(2):232-9. PubMed ID: 18237790
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum uric acid and body mass index to mortality in high-risk patients with established coronary artery disease: a report from the ET-CHD registry, 1997-2006.
Li YH; Lin GM; Lin CL; Wang JH; Chen YJ; Han CL
J Cardiol; 2013 Dec; 62(6):354-60. PubMed ID: 23838556
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.
Kuo CF; See LC; Yu KH; Chou IJ; Chiou MJ; Luo SF
Rheumatology (Oxford); 2013 Jan; 52(1):127-34. PubMed ID: 22923756
[TBL] [Abstract][Full Text] [Related]
9. Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.
Skak-Nielsen H; Torp-Pedersen C; Finer N; Caterson ID; Van Gaal L; James WP; Maggioni AP; Sharma AM; Coutinho W; Andersson C
PLoS One; 2013; 8(3):e59121. PubMed ID: 23533601
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease.
Madsen TE; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Jackson JD; Lappe JM; Pearson RR; Anderson JL
Am J Nephrol; 2005; 25(1):45-9. PubMed ID: 15724082
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
12. Association of uric acid with mortality in patients with stable coronary artery disease.
Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
[TBL] [Abstract][Full Text] [Related]
13. Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Eur Heart J; 2016 Apr; 37(13):1072-8. PubMed ID: 26396230
[TBL] [Abstract][Full Text] [Related]
14. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.
Pilz S; Tomaschitz A; Drechsler C; Ritz E; Boehm BO; Grammer TB; März W
Eur Heart J; 2010 Jul; 31(13):1591-8. PubMed ID: 20439261
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure.
Tomaschitz A; Pilz S; Ritz E; Morganti A; Grammer T; Amrein K; Boehm BO; März W
Eur Heart J; 2011 Nov; 32(21):2642-9. PubMed ID: 21606079
[TBL] [Abstract][Full Text] [Related]
17. Uric Acid and Cardiovascular Events: A Mendelian Randomization Study.
Kleber ME; Delgado G; Grammer TB; Silbernagel G; Huang J; Krämer BK; Ritz E; März W
J Am Soc Nephrol; 2015 Nov; 26(11):2831-8. PubMed ID: 25788527
[TBL] [Abstract][Full Text] [Related]
18. Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography.
Silbernagel G; Rosinger S; Grammer TB; Kleber ME; Winkelmann BR; Boehm BO; März W
Atherosclerosis; 2012 Apr; 221(2):551-7. PubMed ID: 22305263
[TBL] [Abstract][Full Text] [Related]
19. The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Høieggen A; Alderman MH; Kjeldsen SE; Julius S; Devereux RB; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Chen C; Dahlöf B;
Kidney Int; 2004 Mar; 65(3):1041-9. PubMed ID: 14871425
[TBL] [Abstract][Full Text] [Related]
20. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
